EyePoint Pharmaceuticals (United States)

Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: A 3-Year Multicenter, Randomized, Controlled Clinical Trial

P. Andrew Pearson, Timothy L. Comstock, Michael S. Ip et al. · Ophthalmology · 2011 · 207 citations

Ocular Disease, Vitreous Body, Ophthalmology +6

Sustained Delivery Fluocinolone Acetonide Vitreous Implants

José Cunha‐Vaz, Paul Ashton, Raymond Iezzi et al. · Ophthalmology · 2014 · 152 citations

Effect of an Injectable Fluocinolone Acetonide Insert on Recurrence Rates in Chronic Noninfectious Uveitis Affecting the Posterior Segment

Glenn J. Jaffe, C. Stephen Foster, Carlos Pavésio et al. · Ophthalmology · 2018 · 94 citations

Injectable Fluocinolone Acetonide Long-Acting Implant for Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis

Glenn J. Jaffe, Phoebe Lin, Robert T. Keenan et al. · Ophthalmology · 2016 · 58 citations

Ophthalmology, Surgery, Noninfectious Intermediate Uveitis +2

Intravitreous Delivery of the Corticosteroid Fluocinolone Acetonide Attenuates Retinal Degeneration in S334ter-4 Rats

Inna V. Glybina, Alexander Kennedy, Paul Ashton et al. · Investigative Ophthalmology & Visual Science · 2010 · 52 citations · Full text